One issue we are going to have is our trials, although
One issue we are going to have is our trials, although supposedly going to be smaller in size per Joe, are going to take longer to fill. With Pfizer and Moderna vaccines going out, people will want the real thing and not be in a trial. If the trials don't get started until before March 2021, we are going to start having trouble even finding participants to inoculate. Yes, maybe 50% of the US population will want to get vaccinated, however the other 50% won't want a vaccine or a trial. We are running out of time.
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Growth of the Automotive Catalysts Market The automotive industry is experiencing notable growth in its need for innovative emission control technologies. This surge is primarily fueled by the increasing implementation of stringent environmental regulations and the collective aim for cleaner transportation solutions. The automotive catalysts market, valued at around US$...
Continue Reading
Innovative Steps in AI Integration by Aurora Mobile SHENZHEN, China -- Aurora Mobile Limited (NASDAQ: JG), a prominent player in customer engagement and marketing technology, is making waves within the tech industry. The Company has announced an exciting initiative to integrate three advanced language models from Alibaba's renowned Qwen series. This strategic move...
Continue Reading
Nathaniel Ru's Major Transaction at Sweetgreen Sweetgreen, Inc. (NYSE: SG) has recently disclosed a significant transaction involving their Chief Brand Officer, Nathaniel Ru. According to the latest filings, he sold 38,295 shares of Class A Common Stock, totaling over $1.3 million. Details of the Sale This sale was executed at a weighted average price of $35.08 per share,...
Continue Reading
Celebrating Excellence in Golf Professionalism KemperSports has recognized Andrew Blockinger, the head golf professional at Holly Hills, with the Emil Esposito Golf Professional of the Year Award. This announcement came during the annual KemperSports Leadership Conference, where golf professionals gather to celebrate achievements in the golf community. A Testament to...
Continue Reading
XPeng's Impressive Financial Performance Chinese electric vehicle manufacturer XPeng Inc (NYSE: XPEV) has recently made headlines, revealing its substantial revenue growth and ambitious plans for the future. The company announced that it achieved an impressive quarterly revenue of 20.38 billion Chinese yuan, which is approximately $2.86 billion. This figure represents a...
Continue Reading
